Výsledky vyhledávání - "Aude Roborel De Climens"

Akademický článek

Perspectives of patients with advanced or metastatic non-small cell lung cancer on symptoms, impacts on daily activities, and thresholds for meaningful change: a qualitative research study

Autor: Anna Cardellino, Manasee Shah, Jennifer Hanlon, Kimberly Kelly, Alexandra Martin, Aude Roborel de Climens, Sara Taiyari, Alexander Stojadinovic

Publikováno v: Frontiers in Psychology, Vol 14 (2023)

IntroductionAdvanced or metastatic non-small cell lung cancer (NSCLC) is associated with significant symptom burden. It is important to understand the impact of these disease-and treatment-related symptoms on patients’ daily lives and explore from

Externí odkaz: https://doaj.org/article/0ab1f00694454f7f91a498d427b2e2ec

Zobrazit plný text záznamu

Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers

Autor: Jean-François Yale, Aude Roborel de Climens, Naresh Aggarwal, Terry Dex, Hertzel C. Gerstein, Stewart Harris, Irene Hramiak, John Stewart, Lawrence A. Leiter

Publikováno v: Diabetes Therapy. 14:377-386

For people with type 2 diabetes mellitus who do not achieve glycated hemoglobin A1C targets after treatment with basal insulin therapies, additional therapy with a glucagon-like peptide-1 receptor agonist (GLP-1 RA) may be required. One option is to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71a6478ed9d8e760bf3d36f1afca0f67
https://doi.org/10.1007/s13300-022-01353-6

Zobrazit plný text záznamu

813-P: Treatment Satisfaction and Health Status in People with T2D Treated with Insulin Glargine 300 U/mL (Gla-300) : Patient-Reported Outcomes (PRO) from ATOS Study

Autor: NIAZ KHAN, AMIR TIROSH, ANIL BHANSALI, HERNANDO VARGAS-URICOECHEA, STEWART B. HARRIS, AUDE ROBOREL DE CLIMENS, MARIA AILEEN N. MABUNAY, MATHIEU COUDERT, VALERIE PILORGET, GAGIK R. GALSTYAN

Publikováno v: Diabetes. 71

Patients' satisfaction is a key determinant of treatment adherence and persistence, for optimal management of T2D. ATOS, a 12-month prospective observational study conducted in Asia, Middle East, North Africa, Latin America, and Eastern Europe, showe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b444601c829d210c89ef185146b0501
https://doi.org/10.2337/db22-813-p

Zobrazit plný text záznamu

Living with Stargardt disease: insights from patients and their parents

Autor: Aude Roborel de Climens, Carla Dias Barbosa, Catherine Brun-Strang, Ronald Buggage, Béatrice Tugaut

Publikováno v: Ophthalmic Genetics. 42:150-160

Background: Stargardt disease (STGD), a rare, inherited macular degeneration most commonly affecting children and young adults, is a rapidly progressive disease leading to severe central vision los...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f92a7c49966ef84d404ae5974d39c436
https://doi.org/10.1080/13816810.2020.1855663

Zobrazit plný text záznamu

Understanding Reasons for Treatment Discontinuation, Attitudes and Education Needs Among People Who Discontinue Type 2 Diabetes Treatment: Results from an Online Patient Survey in the USA and UK

Autor: Alka Shaunik, Emilie Pain, Aude Roborel De Climens, Anders H. Boss

Publikováno v: Diabetes Therapy

Introduction Type 2 diabetes mellitus (T2DM) requires long-term treatment to achieve and maintain glycaemic control; however, up to 50% of people with T2DM discontinue treatment by 1 year. It is therefore important to understand the patient perspecti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d147ff13a802c76ca51675ea6e4b79d2
https://doi.org/10.1007/s13300-020-00843-9

Zobrazit plný text záznamu

Plný text ve formátu HTML

Development and First Use of the Patient’s Qualitative Assessment of Treatment (PQAT) Questionnaire in Type 2 Diabetes Mellitus to Explore Individualised Benefit–Harm of Drugs Received During Clinical Studies

Autor: Amy Findley, My-Liên Nguyên-Pascal, Aude Roborel de Climens, Matthew Reaney, Catherine Brun-Strang, Adam Gater, Kate Burrows

Publikováno v: Drug Safety

Introduction Individualised benefit–harm assessments can help identify patient-perceived benefits and harms of a treatment, and associated trade-offs that may influence patients’ willingness to use a treatment. This research presents the first us

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e76ee33f29712e377a1d9c1f0a387b47
http://europepmc.org/articles/PMC7007419

Zobrazit plný text záznamu

Take Control: A randomized trial evaluating the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes

Autor: Elías Delgado, Aude Roborel de Climens, Luiza Popescu, Krzysztof Strojek, Hans A. Frandsen, George Dimitriadis, Bernd Schultes, Melanie J. Davies, Mireille Bonnemaire, Arnaud Dauchy, David Russell-Jones

Publikováno v: Diabetes, Obesity & Metabolism
Scopus
RUO. Repositorio Institucional de la Universidad de Oviedo
instname

Aim To compare the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL (Gla‐300) in people with inadequately controlled type 2 diabetes. Methods Take Control (EudraCT number: 2015‐001626‐42) was a 24

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c412d1bd43071d362b669f467b000da5
https://doi.org/10.1111/dom.13697

Zobrazit plný text záznamu

Patient‐reported outcomes in adults with type 1 diabetes in global real‐world clinical practice: the SAGE study

Autor: Grégory Bigot, Zsolt Bosnyak, Lori Berard, Emma G. Wilmot, Luis Eduardo Calliari, Daniela Bruttomesso, F. Javier Ampudia-Blasco, Anne L. Peters, Jochen Seufert, Dubravka Jurišić-Eržen, Eric Renard, Aude Roborel de Climens, Kelly L. Close

Publikováno v: Diabetes, Obesity and Metabolism
Diabetes, Obesity and Metabolism, Wiley, 2021, 23 (8), pp.1892-1901. ⟨10.1111/dom.14416⟩
Diabetes, Obesity and Metabolism, 2021, 23 (8), pp.1892-1901. ⟨10.1111/dom.14416⟩

International audience; Aims: This secondary analysis of the SAGE study aimed to evaluate the association between glycaemic control and patient-reported outcomes (PROs), in adults with type 1 diabetes (T1DM) across different age groups and regions.Ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1763bf708cc1f8afe57783b01384ef3f
https://hal.archives-ouvertes.fr/hal-03218691

Zobrazit plný text záznamu

1629-P: Association of Patient-Reported Outcomes (PROs) Scores with Glycemic Target Achievement in Type 1 Diabetes (T1D) in the SAGE Study

Autor: Kelly L. Close, Eric Renard, Anne L. Peters, Emma G. Wilmot, Luis Eduardo Calliari, Francisco Javier Ampudia Blasco, Emily Fitts, Sandrine Brette, Felipe Lauand, Aude Roborel De Climens, Lori Berard, Jochen Seufert, Juan José Gagliardino

Publikováno v: Diabetes. 69

T1D is a chronic disease affecting both physical and psychosocial health. SAGE was a multinational, cross-sectional observational study using data from medical records and interviews of people (N=3858) aged ≥26 years with T1D for ≥1 year. The ass

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1f2e339cde4df3733ad5fa8aa979a381
https://doi.org/10.2337/db20-1629-p

Zobrazit plný text záznamu

2192-PUB: Treatment Satisfaction in People with Type 2 Diabetes (T2D) Receiving Basal Insulin (BI): Results from Real-World Studies and Randomized Controlled Trials (RCTs) with Insulin Glargine 300 U/mL (Gla-300)

Autor: Jukka Westerbacka, Luigi Meneghini, Stewart B. Harris, Aude Roborel De Climens, Frank J. Snoek, Felipe Lauand, Kamlesh Khunti

Publikováno v: Diabetes. 69

BI analogs can help optimize glycemic control in people with T2D, but the patients’ satisfaction is key for acceptance and treatment adherence. ACHIEVE, REACH, and REGAIN were open-label real-world studies comparing Gla-300 with standard of care BI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::04657d78881195845379d401d3f6def1
https://doi.org/10.2337/db20-2192-pub

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání